Hello. It looks like you’re using an ad blocker that may prevent our website from working properly. To receive the best Tortoise experience possible, please make sure any blockers are switched off and refresh the page.

If you have any questions or need help, let us know at memberhelp@tortoisemedia.com

Friend of Tortoise Exclusive

The forgotten 500,000: why is the UK government blocking Evusheld?

The forgotten 500,000: why is the UK government blocking Evusheld?

This event is exclusive to Friends of Tortoise

This is a digital-only ThinkIn.

While most of society returned to normal after the pandemic, there are still half a million immunocompromised people in the UK who are trapped in their homes. Many are still shielding, still in isolation. Still unable to work, see friends or hug loved ones.

It doesn’t have to be this way. Fortunately there is a treatment called Evusheld which can protect the immunocompromised against the threat of covid. It’s a treatment developed and manufactured in the UK, and approved in 32 countries.

Evusheld could offer freedom to the half a million immunocompromised Brits who can’t leave their homes – but, for some reason, the UK government won’t authorise its use.

Join us for a special ThinkIn where we try to understand why Evusheld is being blocked in the same country that makes it, and the impact this decision is having on the people who just want their lives back.

editor and invited experts

James Harding
Editor and Co-founder

Daisy Cooper
MP

Dr Lennard Lee
Academic Clinical Lecturer in Medical Oncology at the University of Oxford

Helen Rowntree
Director of Research, Blood Cancer UK

Lord Mendelsohn

Mark Oakley
Evusheld for the UK